AKT1 and cutaneous melanoma: In another study, however, silencing of CB1 using shRNAs, led to a slowing in the cell cycle in the G1-S phase, which was accompanied by reduced activation of protein kinase B (Akt) and ERK, suggesting a possible function of the CB1 receptor as a tumour-promoting signal in human skin melanomas [92].